Skip to content
Peptigraph home

What does retatrutide do to your body?

The clearest effect is weight loss: in the obesity dose-finding trial, the 12 mg group lost 24.2% of body weight over 48 weeks against 2.1% on placebo.

GLP-1 / GIP / glucagon triple agonistUpdated

Short answer

The clearest effect is weight loss: in the obesity dose-finding trial, the 12 mg group lost 24.2% of body weight over 48 weeks against 2.1% on placebo.[1]

Blood pressure, lipids and liver

A meta-analysis found systolic blood pressure fell by 6.79 mmHg and diastolic by 2.46 mmHg.[2]

The same meta-analysis found LDL cholesterol down by 13.10 mg/dL and triglycerides down by 40.90 mg/dL, with no significant change in HDL.[2]

In people with fatty liver disease, liver fat fell by 82.4% at 24 weeks on 12 mg, against a 0.3% rise on placebo.[3]

What it does on the other side

Gastrointestinal events were the most common side effects in the large obesity trial.[4]

Heart rate rose with dose in the dose-finding trial and then declined after week 24.[1]

More on Retatrutide

Sources

  1. 1Triple-Hormone-Receptor Agonist Retatrutide for Obesity - A Phase 2 Trial.The New England journal of medicine · 2023PMID 37366315Accessed 2 Oct 2026
  2. 2Effect of Retatrutide, a Novel Triple Receptor Agonist, on Blood Pressure and Lipid Levels: A Systematic Review and Meta-analysis of Randomized Controlled Trials.High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension · 2026PMID 42371360Accessed 2 Oct 2026
  3. 3Triple hormone receptor agonist retatrutide for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a trial.Nature medicine · 2024PMID 38858523Accessed 2 Oct 2026
  4. 4Retatrutide, a Triple Hormone Receptor Agonist, for Treatment of Obesity.The New England journal of medicine · 2026PMID 42814954Accessed 2 Oct 2026

Found an error? Report a correction.